In vitro cell transformation assays for an integrated, alternative assessment of carcinogenicity: A data-based analysis

Mutagenesis

Volumn 28, Issue 1, 2013, Pages 107-116

  Benigni, Romualdo ^a   Bossa, Cecilia ^a   Tcheremenskaia, Olga ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; DNA;

ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL TRANSFORMATION; DATA ANALYSIS; EMBRYO CELL; GENETIC ANALYSIS; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; PH; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STRUCTURE ANALYSIS;

ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; CELL LINE, TRANSFORMED; CRICETINAE; EMBRYO, MAMMALIAN; MESOCRICETUS; RODENTIA; STATISTICS AS TOPIC;

MESOCRICETUS AURATUS;

EID: 84871807809     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ges059     Document Type: Article

References (82)

1. Belpomme, D., Irigaray, P., Hardell, L., Clapp, R., Montagnier, L., Epstein, S. and Sasco, A. J. (2007) The multitude and diversity of environmental carcinogens. Environ. Res., 105, 414-429 (Pubitemid 47554416)
2. Benigni, R. and Bossa, C. (2011) Mechanisms of chemical carcinogenicity and mutagenicity: A review with implications for predictive toxicology. Chem. Rev., 111, 2507-2536
3. Frankish, H. (2003) 15 million new cancer cases per year by 2020, says WHO. Lancet, 361, 1278
4. Tomatis, L., Huff, J., Hertz-Picciotto, I. et al. (1997) Avoided and avoidable risks of cancer. Carcinogenesis, 18, 97-105 (Pubitemid 28134622)
5. Sokal, R. R., Oden, N. L., Rosenberg, M. S. and Thomson, B. A. (2000) Cancer incidences in Europe related to mortalities, and ethnohistoric, genetic, and geographic distances. Proc. Natl Acad. Sci. USA 97, 6067-6072 (Pubitemid 30367524)
6. Belpomme, D., Irigaray, P., Sasco, A. J., Newby, J. A., Howard, V., Clapp, R. and Hardell, L. (2007) The growing incidence of cancer: Role of lifestyle and screening detection. Int. J. Oncol., 30, 1037-1049
7. Liechtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. and Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer. N. Engl. J. Med., 343, 78-84
8. Benigni, R. (2007) Social sexual inequality, and sex difference in cancer incidence. Environ. Res., 104, 128-134 (Pubitemid 46560493)
9. Haseman, J. K., Melnick, R. L., Tomatis, L. and Huff, J. (2001) Carcinogenesis bioassays: Study duration and biological relevance. Food Chem. Toxicol., 39, 739-744 (Pubitemid 32536733)
10. Tomatis, L., Melnick, R. L., Haseman, J. K., Barrett, J. C. and Huff, J. (2001) Alleged 'misconceptions' distort perceptions of environmental cancer risks. FASEB J., 15, 195-203 (Pubitemid 32061670)
11. Bucher, J. R. (2000) Doses in rodent cancer studies: Sorting fact from fiction. Drug Metab. Rev., 32, 153-163 (Pubitemid 30198555)
12. Huff, J. (1999) Long-term chemical carcinogenesis bioassays predict human cancer hazards. Issues, controversies, and uncertainties. Ann. N. Y. Acad. Sci., 895, 56-79 (Pubitemid 30040546)
13. Huff, J. (1999) Value, validity, and historical development of carcinogenesis studies for predicting and confirming carcinogenic risks to humans. In Kitchin, K. T. (ed.), Carcinogenicity. Testing, Predicting, and Interpreting Chemical Effects. Marcel Dekker, New York, pp. 21-123
14. Fung, V. A., Huff, J., Weisburger, E. K. and Hoel, D. G. (1993) Predictive strategies for selecting 379 NCI/NTP chemicals evaluated for carcinogenic potential: Scientific and public health impact. Fund. Appl. Toxicol., 20, 413-436 (Pubitemid 23156040)
15. Huff, J. E., Haseman, J. K. and Rall, D. P. (1991) Scientific concepts, value, and significance of chemical carcinogenesis studies. Annu. Rev. Pharmacol. Toxicol., 31, 621-625
16. Tomatis, L. (2006) Identification of carcinogenic agents and primary prevention of cancer. Ann. N. Y. Acad. Sci., 1076, 1-14 (Pubitemid 44970391)
17. Tomatis, L. (2005) Primary prevention of cancer in relation to science, sociocultural trends and economic pressures. Scand. J. Work Environ. Health, 31, 165-167
18. Huff, J. (2011) Primary prevention of cancer. Science, 332, 916-917
19. European Commission (2003) Proposal concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). COM(2003)644Final
20. Pedersen, F., de Brujin, J., Munn, S. J. and Van Leeuwen, K. (2003) Assessment of Additional Testing Needs under REACH. Effects of (Q)SARs, Risk Based Testing and Voluntary Industry Initiatives. JRC report EUR 20863 EN. European Commission, Joint Research Centre, Ispra, Italy
21. Van der Jagt, K., Munn, S. J., Torslov, J. and de Brujin, J. (2004) Alternative Approaches Can Reduce the Use of Test Animals under REACH. Addendum to the Report 'Assessment of Additional Testing Needs under REACH. Effects of (Q)SARs, Risk Based Testing and Voluntary Industry Initiatives'. JRC Report EUR 21405 EN. European Commission, oint Research Centre, Ispra, Italy
22. Zeiger, E. (2010) Historical perspective on the development of the genetic toxicity test battery in the United States. Environ. Mol. Mutagen., 51, 781-791
23. Zeiger, E. (2004) History and rationale of genetic toxicity testing: An impersonal, and sometimes personal, view. Environ. Mol. Mutagen., 44, 363-371 (Pubitemid 40136602)
24. Zeiger, E. (1998) Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: Premises, promises, and performance. Regulat. Pharmacol. Toxicol., 28, 85-95 (Pubitemid 29076774)
25. Hansch, C. (1991) Structure-activity relationships of chemical mutagens and carcinogens. Sci. Total Environ., 109-110, 17-29
26. Benigni, R., Netzeva, T. I., Benfenati, E. et al. (2007) The expanding role of predictive toxicology: An update on the (Q)SAR models for mutagens and carcinogens. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev., 25, 53-97 (Pubitemid 46393120)
27. Hansch, C., Kim, D., Leo, A. J., Novellino, E., Silipo, C. and Vittoria, A. (1989) Toward a quantitative comparative toxicology of organic compounds. Crit. Rev. Toxicol., 19, 185-226 (Pubitemid 19088717)
28. Worth, A. P., Bassan, A., de Brujin, J., Gallegos Saliner, A., Netzeva, T. I., Pavan, M., Patlewicz, G., Tsakovska, I. and Eisenreich, S. (2007) The Role of the European Chemicals Bureau in promoting the regulatory use of (Q) SAR methods. SAR QSAR Environ. Res., 18, 111-125
29. Van Leeuwen, K., Schultz, T. W., Henry, T., Diderich, B. and Veith, G. D. (2009) Using chemical categories to fill data gaps in hazard assessment. SAR QSAR Environ. Res., 20, 207-220
30. Worth, A. P. (2010) The role of QSAR methodology in the regulatory assessment of chemicals. In Puzyn, T., Leszczynski, J. and Cronin, M. T. D. (eds.), Recent Advances in QSAR Studies: Methods and Applications. Springer, Heidelberg, pp. 367-382
31. Baker, S. G., Cappuccio, A. and Potter, J. D. (2010) Research on early-stage carcinogenesis: Are we approaching paradigm instability? J. Clin. Oncol., 28, 3215-3218
32. Benigni, R. (2012) Alternatives to the carcinogenicity bioassay for toxicity prediction: Are we there yet? Exp. Opin. Drug Metab. Toxicol., 8, 1-11
33. Zeiger, E. (1994) Strategies and philosophies of genotoxicity testing: What is the question? Mutat. Res., 304, 309-314
34. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (2008) Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. S2(R1). ICH, Geneva, Switzerland
35. Kirkland, D. and Speit, G. (2008) Evaluation of the ability of a battery of three in vitro genotoxicity ests to discriminate rodent carcinogens and noncarcinogens III. Appropriate follow-up testing in vivo. Mutat. Res., 654, 114-132
36. Elespuru, R. K., Agarwal, R., Atrakchi, A. H. et al. (2009) Current and future application of genetic toxicity assays: The role and value of in vitro mammalian assays. Toxicol. Sci., 109, 172-179
37. EFSA (2011) Scientific opinion on genotoxicity testing strategies applicable to food and feed safety assessment. EFSA J., 9, 2379
38. Kirkland, D., Aardema, M. J., Henderson, L. and Muller, L. (2005) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat. Res., 584, 1-256 (Pubitemid 40922793)
39. Benigni, R., Bossa, C., Tcheremenskaia, O. and Giuliani, A. (2010) Alternatives to the carcinogenicity bioassay: In silico methods, and the in vitro and in vivo mutagenicity assays. Exp. Opin. Drug Metab. Toxicol., 6, 1-11
40. Benigni, R., Bossa, C., Tcheremenskaia, O., Battistelli, C. L. and Crettaz, P. (2012) The New ISSMIC Database on in vivo micronucleus, and its role in assessing genotoxicity testing strategies. Mutagenesis, 27, 87-92
41. Lai, D. Y. and Woo, Y. T. (2012) Reducing carcinogenicity and mutagenicity through mechanism-based molecular design of chemicals. In Boethling, R. S. and Voutchkova, A. M. (eds.), Green Processes. Volume 9: Designing Safer Chemicals. Wiley, Heidelberg
42. Woo, Y. T. (2003) Mechanisms of action of chemical carcinogens, and their role in structure-activity elationships (SAR) analysis and risk assessment. In Benigni, R. (ed.), Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens. CRC Press, oca Raton, FL, pp. 41-80
43. Melnick, R. L., Kohn, M. C. and Portier, C. J. (1996) Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis. Environ. Health Perspect., 104, 123-134 (Pubitemid 26123097)
44. Huff, J. (2008) More toxin tests needed. Science, 319, 725-726
45. Hernandez, L. G., van Steeg, H., Luijten, M. and van Benthem, J. (2009) Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. Mutat. Res., 682, 94-109
46. Barrett, J. C. and Ts'o, P. O. (1978) Evidence for the progressive nature of neoplastic transformation in vitro. Proc. Natl Acad. Sci. USA 75, 3761-3765 (Pubitemid 8399280)
47. Berwald, Y. and Sachs, L. (1965) In vitro transformation of normal cells to tumour cells by carcinogenic hydrocarbons. J. Natl Cancer Inst., 35, 641-661
48. Berwald, Y. and Sachs, L. (1963) In vitro cell transformation with chemical carcinogens. Nature, 200, 1182-1184
49. OECD (2007) Detailed Review Paper on Cell Transformation Assays for Detection of Chemical Carcinogens. OECD Series on Testing and Assessment, No. 31. OECD, Paris
50. Vasseur, P. and Lasne, C. (2012) OECD Detailed Review Paper (DRP) number 31 on 'Cell Transformation Assays for Detection of Chemical Carcinogens': Main results and conclusions. Mutat. Res., 744, 8-11
51. Corvi, R., Aardema, M. J., Gribaldo, L., Hayashi, M., Hoffmann, S., Schechtman, L. M. and Vanparys, P. (2011) ECVAM prevalidation study on in vitro cell transformation assays: General outline and conclusions of the study. Mutat. Res., 744, 12-19
52. Vanparys, P., Corvi, R., Aardema, M. J., Gribaldo, L., Hayashi, M., Hoffmann, S. and Schechtman, L. M. (2012) Application of in vitro cell transformation assays in regulatory toxicology for pharmaceuticals, chemicals, food products and cosmetics. Mutat. Res., 744, 111-118
53. Benigni, R. and Bossa, C. (2011) Alternative strategies for carcinogenicity assessment: An efficient and simplified approach based on in vitro mutagenicity and cell transformation assays. Mutagenesis, 26, 455-460
54. Sakai, A., Sasaki, K., Muramatsu, D. et al. (2010) A Bhas 42 cell transformation assay on 98 chemicals: The characteristics and performance for the prediction of chemical carcinogenicity. Mutat. Res., 702, 100-122
55. Benigni, R., Bossa, C., Richard, A. M. and Yang, C. (2008) A novel approach: Chemical relational databases, and the role of the ISSCAN database on assessing chemical carcinogenicity. Ann. Ist. Super. Sanità, 44, 48-56
56. Ashby, J. (1985) Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity. Environ. Mutagen., 7, 919-921 (Pubitemid 16180586)
57. Miller, E. C. and Miller, J. A. (1981) Mechanisms of chemical carcinogenesis. Cancer, 47, 1055-1064 (Pubitemid 11159574)
58. Miller, J. A. and Miller, E. C. (1977) Ultimate chemical carcinogens as reactive mutagenic electrophiles. In Hiatt, H. H., Watson, J. D. and Winsten, J. A. (eds.), Origins of Human Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp. 605-628
59. Benigni, R. and Bossa, C. (2008) Structure alerts for carcinogenicity, and the Salmonella assay system: A novel insight through the chemical relational databases technology. Mutat. Res. Rev., 659, 248-261
60. Benigni, R., Bossa, C., Jeliazkova, N. G., Netzeva, T. I. and Worth, A. P. (2008) The Benigni/Bossa Rulebase for Mutagenicity and Carcinogenicity - A Module of Toxtree. EUR 23241 EN. Office for the Official Publications of the European Communities, EUR - Scientific and Technical Report Series, Luxembourg
61. Swets, J. A. (1988) Measuring the accuracy of diagnostic systems. Science, 240, 1285-1293
62. Kraemer, H. C. (1988) Assessment of 2x2 associations: Generalization of signal-detection methodology. Am. Stat., 42, 37-49
63. Benigni, R. and Giuliani, A. (1994) Quantitative modeling and biology: The multivariate approach. Am. J. Physiol., 266, R1697-R1704 (Pubitemid 24169361)
64. Sneath, P. H. A. (1983) Distortions of taxonomic structure from incomplete data on a restricted set of reference strains. J. Gen. Microbiol., 129, 1045-1073 (Pubitemid 13102855)
65. Lebart, L., Morineau, A. and Warwick, K. M. (1984) Multivariate Descriptive Statistical Analysis. Wiley, New York
66. Maire, M. A., Pant, K., Phrakonkham, P. et al. (2012) Recommended protocol for the Syrian hamster embryo (SHE) cell transformation assay. Mutat. Res., 744, 76-81
67. Creton, S., Aardema, M. J., Carmichael, P. et al. (2012) Cell transformation assays for prediction of carcinogenic potential: State of the science and future research needs. Mutagenesis, 62, 93-101
68. Mauthe, R. J., Gibson, D. P., Bunch, R. T. and Custer, L. (2001) The Syrian Hamster Embryo (SHE) cell transformation assay: Review of the methods and results. Toxicol. Pathol., 29, 138-146
69. Haga, K., Ohno, S., Yugawa, T., Narisawa-Saito, M., Fujita, M., Sakamoto, M., Galloway, D. A. and Kiyono, T. (2007) Efficient immortalization of primary human cells by p.16INK4a-specific short hairpin RNA or Bmi-1, combined with introduction of hTERT. Cancer Sci., 98, 147-154 (Pubitemid 44941865)
70. Nguyen-Ba, G. and Vasseur, P. (1999) Epigenetic events during the process of cell transformation induced by carcinogens (review). Oncol. Rep., 6, 925-932
71. Benigni, R., Bossa, C., Giuliani, A. and Tcheremenskaia, O. (2010) Exploring in vitro/in vivo correlations: Lessons learned from analyzing phase I results of U.S. EPA's ToxCast project. J. Environ. Sci. Health. C Environ. Carcinog. Ecotoxicol. Rev., 28, 272-286
72. Bignami, M., Ficorella, C., Dogliotti, E., Norman, R. L., Kaighn, M. E. and Saffiotti, U. (1984) Temporal dissociation in the exposure times required for maximal induction of cytotoxicity, mutation, and transformation by N-methyl-N'-nitro-N-nitrosoguanidine in the BALB/3T3 ClA31-1-1 cell line. Cancer Res., 44, 2452-2457 (Pubitemid 14110666)
73. Kalluri, R. and Zeisberg, M. (2006) Fibroblasts in cancer. Nat. Rev. Cancer, 6, 392-401
74. Soto, A.M. and Sonnenschein, C. (2011) The tissue organization field theory of cancer: A testable replacement for the somatic mutation theory. Bioassays, 33, 332-340
75. Potter, J. D. (2007) Morphostats, morphogens, microarchitecture and malignancy. Nat. Rev. Cancer, 7, 464-474
76. Kavlock, R. J., Austin, C. P. and Tice, R. R. (2009) Toxicity testing in the 21st century: Implications for human health risk assessment. Risk Anal., 29, 485-487
77. Ankley, G. T., Bennett, R. S., Erickson, R. J. et al. (2011) Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem., 29, 730-741
78. Butcher, E. C. (2005) Can cell systems biology rescue drug discovery? Nat. Rev. Drug Discov., 4, 461-467 (Pubitemid 40861988)
79. May, R. M. (2001) Stability and Complexity in Model Ecosystems. Princeton University Press, Princeton. 80. Badii, R. and Politi, A. (1997) Complexity. Hierarchical Structures and Scaling in Physics. Cambridge University Press, Cambridge. 81. MacDonald, J. S. and Robertson, R. T. (2009) Toxicity testing in the 21st century: A view from the pharmaceutical industry. Toxicol. Sci., 110, 40-46
80. Perera, F. P. (1991) Perspectives on the risk assessment for non-genotoxic carcinogens and tumor promoters. Environ. Health Perspect., 94, 231-235
81. Yamasaki, H. (1995) Non-genotoxic mechanisms of carcinogenesis: Studies of cell transformation and gap junctional intercellular communication. Toxicol. Lett., 77, 55-61
82. Hansch, C., Vittoria, A., Silipo, C. and Jow, P. Y. (1975) Partition coefficients and the structure-activity relationships of the anesthetic gases. J. Med. Chem., 18, 546-548.